2020 Annual Meeting | C2 - Update on Medical Management of Stroke
| 07:00 AM - 08:00 AM | Speaker |
Acute Medical Management
Adam De Havenon, MD, FAAN, Claire Creutzfeldt, MD |
| 08:00 AM - 09:00 AM | Speaker |
Sub-acute Medical Management
Adam De Havenon, MD, FAAN, Amy K. Guzik, MD, FAAN |
| Adam De Havenon, MD, FAAN | Dr. De Havenon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. De Havenon has or had stock in Certus.Dr. De Havenon has or had stock in TitinKM. The institution of Dr. De Havenon has received research support from NIH/NINDS. Dr. De Havenon has received publishing royalties from a publication relating to health care. |
| Claire Creutzfeldt, MD | The institution of Dr. Creutzfeldt has received research support from NINR. The institution of Dr. Creutzfeldt has received research support from NIA. |
| Amy K. Guzik, MD, FAAN | Dr. Guzik has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Local law firms, available by request. |